Justyna Jusiak
Justyna Jusiak has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Paulina Halik
The Baptism of Poland Memorial Hospital, ul. Świętego Jana 9, 62-200 Gniezno, Poland
9 shared publications - Janusz Łuczak
Polish Mother's Memorial Hospital-Research Institute, Lodz, Poland
5 shared publications - Jeremi Łuczak5 shared publications
- Justyna Dżumaga5 shared publications
- Maciej Sobkowiak5 shared publications
- Marta Walaszek5 shared publications
Latest Publications
- Open Access
- 15 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
Current strategies in the management of melasma: pathogenesis, risk factors and comprehensive treatment approaches
Melasma is an acquired pigmentary disorder characterized by symmetric hyperpigmented macules and patches on sun‑exposed facial areas. Its multifactorial pathogenesis includes melanocyte hyperactivity, dermal melanophages, vascular and inflammatory components, oxidative stress and hormonal drivers. Because of its chronic, relapsing nature and high risk of recurrence, melasma management requires individualized, multimodal approaches combining strict photoprotection, topical agents, systemic medications when indicated, and procedure‑based therapies for refractory or mixed cases. This review summarizes current knowledge of pathomechanisms and precipitating factors, evaluates therapeutic options (topical, systemic and procedural), compares modalities, and proposes practical algorithms for management and maintenance.
- 15 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
Open AccessCurrent strategies in the management of melasma: pathogenesis, risk factors and comprehensive treatment approaches
Melasma is an acquired pigmentary disorder characterized by symmetric hyperpigmented macules and patches on sun‑exposed facial areas. Its multifactorial pathogenesis includes melanocyte hyperactivity, dermal melanophages, vascular and inflammatory components, oxidative stress and hormonal drivers. Because of its chronic, relapsing nature and high risk of recurrence, melasma management requires individualized, multimodal approaches combining strict photoprotection, topical agents, systemic medications when indicated, and procedure‑based therapies for refractory or mixed cases. This review summarizes current knowledge of pathomechanisms and precipitating factors, evaluates therapeutic options (topical, systemic and procedural), compares modalities, and proposes practical algorithms for management and maintenance.
- Open Access
- 14 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
How Does the Use of Dating Apps Relate to Physical Health Behaviors and Mental Health? A Narrative Review
Dating applications have become a central component of contemporary romantic and social interactions, particularly among adolescents, young adults, and emerging adults. While these platforms offer opportunities for social connection, accumulating evidence suggests that dating app use may be associated with a range of mental health outcomes and physical health–related behaviors. Research in this area remains fragmented, with findings dispersed across psychological, behavioral, and public health disciplines. Aim. The aim of this narrative review is to synthesize and critically analyze existing research on the relationship between dating app use, mental health outcomes, and physical health behaviors. Material and methods. A narrative review of peer-reviewed literature was conducted using articles provided by the author. The included studies encompassed cross-sectional, longitudinal, diary-based, and review designs examining dating app use in relation to mental health indicators. Results. The reviewed literature indicates that dating app use is associated with diverse mental health outcomes, including depressive symptoms, anxiety, loneliness, body dissatisfaction, and self-esteem fluctuations. Additionally, dating app engagement has been linked to several physical health behaviors, such as risky sexual practices, sexually transmitted infection risk, alcohol and substance use, sleep disturbances, and unhealthy weight-control behaviors. Conclusions. Dating app use appears to be meaningfully related to both mental health and physical health behaviors, although the direction and strength of these associations vary across populations and study designs. Further longitudinal and theory-driven research is needed to clarify causal mechanisms and to inform health education, prevention, and public health interventions.
- 14 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
Open AccessHow Does the Use of Dating Apps Relate to Physical Health Behaviors and Mental Health? A Narrative Review
Dating applications have become a central component of contemporary romantic and social interactions, particularly among adolescents, young adults, and emerging adults. While these platforms offer opportunities for social connection, accumulating evidence suggests that dating app use may be associated with a range of mental health outcomes and physical health–related behaviors. Research in this area remains fragmented, with findings dispersed across psychological, behavioral, and public health disciplines. Aim. The aim of this narrative review is to synthesize and critically analyze existing research on the relationship between dating app use, mental health outcomes, and physical health behaviors. Material and methods. A narrative review of peer-reviewed literature was conducted using articles provided by the author. The included studies encompassed cross-sectional, longitudinal, diary-based, and review designs examining dating app use in relation to mental health indicators. Results. The reviewed literature indicates that dating app use is associated with diverse mental health outcomes, including depressive symptoms, anxiety, loneliness, body dissatisfaction, and self-esteem fluctuations. Additionally, dating app engagement has been linked to several physical health behaviors, such as risky sexual practices, sexually transmitted infection risk, alcohol and substance use, sleep disturbances, and unhealthy weight-control behaviors. Conclusions. Dating app use appears to be meaningfully related to both mental health and physical health behaviors, although the direction and strength of these associations vary across populations and study designs. Further longitudinal and theory-driven research is needed to clarify causal mechanisms and to inform health education, prevention, and public health interventions.
- Open Access
- 14 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
Breastfeeding and postpartum depression mechanisms and care
Objective: To synthesize evidence on the association between breastfeeding and postpartum depression, emphasizing bidirectionality, proposed mechanisms, key modifiers (self-efficacy, stress and social support), and integrated intervention strategies. Methods: Narrative review of the peer-reviewed literature provided by the author, prioritizing meta-analyses, systematic reviews, randomized trials, and large observational or qualitative studies. Results: Across settings, postpartum depressive symptoms are associated with reduced breastfeeding initiation, exclusivity, and duration. Early cessation and negative breastfeeding experiences are also associated with higher depressive symptom burden in some populations. Self-efficacy and social support consistently correlate with both mood and feeding outcomes, and stress appears to amplify risk. Interventions spanning pregnancy through the postpartum period and combining lactation support with psychosocial care show the most consistent promise. Conclusions: Because breastfeeding and postpartum depression influence one another and share modifiable determinants, clinical pathways should integrate screening, individualized feeding support, and stepped mental health care.
- 14 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
Open AccessBreastfeeding and postpartum depression mechanisms and care
Objective: To synthesize evidence on the association between breastfeeding and postpartum depression, emphasizing bidirectionality, proposed mechanisms, key modifiers (self-efficacy, stress and social support), and integrated intervention strategies. Methods: Narrative review of the peer-reviewed literature provided by the author, prioritizing meta-analyses, systematic reviews, randomized trials, and large observational or qualitative studies. Results: Across settings, postpartum depressive symptoms are associated with reduced breastfeeding initiation, exclusivity, and duration. Early cessation and negative breastfeeding experiences are also associated with higher depressive symptom burden in some populations. Self-efficacy and social support consistently correlate with both mood and feeding outcomes, and stress appears to amplify risk. Interventions spanning pregnancy through the postpartum period and combining lactation support with psychosocial care show the most consistent promise. Conclusions: Because breastfeeding and postpartum depression influence one another and share modifiable determinants, clinical pathways should integrate screening, individualized feeding support, and stepped mental health care.
- Open Access
- 14 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
When Campylobacter jejuni affects the heart - myocarditis in male patients
Introduction: Campylobacter jejuni is a bacteria that is one of the most common causes of bacterial foodborne illness worldwide. The bacteria is typically transmitted through consumption of undercooked poultry, contaminated water, or unpasteurized dairy products. In addition to gastrointestinal symptoms such as diarrhea, abdominal cramps or fever, C. jejuni has been associated with post-infection sequelae, including rare cases of myocarditis. Although uncommon, myocarditis can result in arrhythmias, heart failure or even death, requiring prompt medical attention. Methods: This review consists of the latest papers, including cases, systematic reviews and cohorts. The analysis focuses on summarizing the C. jejuni infection-related myocarditis in male patients, in particular determining the time of onset of gastrointestinal and cardiovascular symptoms, and the results of additional tests leading to the diagnosis of myocarditis. Results: Among the 46 reported male patients with Campylobacter jejuni-associated myocarditis or myopericarditis, left ventricular systolic dysfunction was documented in 17 cases (39.5%). The time interval between the onset of gastrointestinal symptoms and the onset of chest pain was available for 43 patients, with a mean delay of 3,84 days (median 3 days; range 0-14 days), indicating a short but clearly discernible latency between enteric infection and myocardial involvement. Overall, only one of the 46 patients (2.2%) died, whereas all others survived to hospital discharge, indicating a generally favourable short-term prognosis despite the relatively high proportion of cases with impaired ventricular function. Conclusions: Proper food handling, cooking poultry to appropriate temperatures, and good hygiene practices are essential for prevention of C. jejuni infections. Quick and precise diagnosis of myocarditis prevents severe complications of the disease.
- 14 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
Open AccessWhen Campylobacter jejuni affects the heart - myocarditis in male patients
Introduction: Campylobacter jejuni is a bacteria that is one of the most common causes of bacterial foodborne illness worldwide. The bacteria is typically transmitted through consumption of undercooked poultry, contaminated water, or unpasteurized dairy products. In addition to gastrointestinal symptoms such as diarrhea, abdominal cramps or fever, C. jejuni has been associated with post-infection sequelae, including rare cases of myocarditis. Although uncommon, myocarditis can result in arrhythmias, heart failure or even death, requiring prompt medical attention. Methods: This review consists of the latest papers, including cases, systematic reviews and cohorts. The analysis focuses on summarizing the C. jejuni infection-related myocarditis in male patients, in particular determining the time of onset of gastrointestinal and cardiovascular symptoms, and the results of additional tests leading to the diagnosis of myocarditis. Results: Among the 46 reported male patients with Campylobacter jejuni-associated myocarditis or myopericarditis, left ventricular systolic dysfunction was documented in 17 cases (39.5%). The time interval between the onset of gastrointestinal symptoms and the onset of chest pain was available for 43 patients, with a mean delay of 3,84 days (median 3 days; range 0-14 days), indicating a short but clearly discernible latency between enteric infection and myocardial involvement. Overall, only one of the 46 patients (2.2%) died, whereas all others survived to hospital discharge, indicating a generally favourable short-term prognosis despite the relatively high proportion of cases with impaired ventricular function. Conclusions: Proper food handling, cooking poultry to appropriate temperatures, and good hygiene practices are essential for prevention of C. jejuni infections. Quick and precise diagnosis of myocarditis prevents severe complications of the disease.
- Open Access
- 14 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
The Role of Gut Microbiota-Targeted Interventions in the Treatment of Depression
Aim: This review summarizes current evidence on the role of gut microbiota modulation using probiotics, prebiotics, and synbiotics in the treatment of depression, with particular emphasis on clinical studies and mechanisms of the gut–brain axis. Introduction: Depression is a prevalent mood disorder affecting more than 280 million people worldwide and is often resistant to standard pharmacological and psychotherapeutic treatments. Growing evidence from animal and human studies indicates that gut microbiota influences brain function and emotional regulation. Dysbiosis may contribute to neuroinflammation, altered neurotransmitter activity, and dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, thereby worsening depressive symptoms. Methods: A review of meta-analyses and randomized controlled trials published between 2016 and 2024 was conducted. Studies included adults with depression or comorbid depression and anxiety who received probiotics, prebiotics, or synbiotics. Depression severity was assessed using validated clinical scales. Results: Probiotic supplementation, particularly multi-strain formulations containing Lactobacillus and Bifidobacterium, was associated with significant reductions in depressive symptoms. Proposed mechanisms include modulation of gut microbiota composition, decreased pro-inflammatory cytokines (IL-1, IL-6), regulation of the HPA axis, effects on neurotransmitter metabolism (serotonin, dopamine, GABA), production of short-chain fatty acids, and vagus nerve activation. Synbiotics may enhance these effects, whereas prebiotics alone showed inconsistent outcomes. Conclusion: Probiotics and synbiotics appear to be safe and promising adjuncts to standard depression treatment. Targeting the gut–brain axis may represent a future direction for personalized psychiatric interventions.
- 14 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 88
Open AccessThe Role of Gut Microbiota-Targeted Interventions in the Treatment of Depression
Aim: This review summarizes current evidence on the role of gut microbiota modulation using probiotics, prebiotics, and synbiotics in the treatment of depression, with particular emphasis on clinical studies and mechanisms of the gut–brain axis. Introduction: Depression is a prevalent mood disorder affecting more than 280 million people worldwide and is often resistant to standard pharmacological and psychotherapeutic treatments. Growing evidence from animal and human studies indicates that gut microbiota influences brain function and emotional regulation. Dysbiosis may contribute to neuroinflammation, altered neurotransmitter activity, and dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis, thereby worsening depressive symptoms. Methods: A review of meta-analyses and randomized controlled trials published between 2016 and 2024 was conducted. Studies included adults with depression or comorbid depression and anxiety who received probiotics, prebiotics, or synbiotics. Depression severity was assessed using validated clinical scales. Results: Probiotic supplementation, particularly multi-strain formulations containing Lactobacillus and Bifidobacterium, was associated with significant reductions in depressive symptoms. Proposed mechanisms include modulation of gut microbiota composition, decreased pro-inflammatory cytokines (IL-1, IL-6), regulation of the HPA axis, effects on neurotransmitter metabolism (serotonin, dopamine, GABA), production of short-chain fatty acids, and vagus nerve activation. Synbiotics may enhance these effects, whereas prebiotics alone showed inconsistent outcomes. Conclusion: Probiotics and synbiotics appear to be safe and promising adjuncts to standard depression treatment. Targeting the gut–brain axis may represent a future direction for personalized psychiatric interventions.
- Open Access
- 3 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51, 68476
Subcutaneous versus Sublingual Allergen Immunotherapy in Allergic Rhinitis and Asthma: A Comparative Narrative Review
Allergen-specific immunotherapy (AIT) represents the only disease-modifying intervention for IgE-mediated allergic diseases, including allergic rhinitis and allergic asthma. Among the currently available administration routes, subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are the most extensively studied and clinically implemented. Despite their widespread use, uncertainty persists regarding their relative efficacy, safety, and real-world applicability across different patient populations and allergen types. AIM: The aim of this study was to critically compare the clinical effectiveness, safety profile, and treatment adherence of SCIT and SLIT based on data derived from PubMed-indexed randomized controlled trials, systematic reviews, and meta-analyses. Material and methods: A narrative synthesis of peer-reviewed literature was conducted, focusing on studies directly or indirectly comparing SCIT and SLIT in patients with allergic rhinitis, allergic asthma, or rhinoconjunctivitis. Primary endpoints included symptom score reduction and medication use, while secondary outcomes encompassed adverse events, immunological responses, and adherence rates. Results: Both SCIT and SLIT demonstrated significant clinical efficacy compared with placebo or pharmacotherapy alone. Overall symptom reduction and medication sparing effects were largely comparable between the two modalities. SCIT showed a trend toward slightly greater efficacy in selected allergens, particularly grass pollen, whereas SLIT consistently exhibited a superior safety profile with fewer systemic adverse reactions. Conclusion: SCIT and SLIT are both effective forms of allergen immunotherapy. While SCIT may provide marginal advantages in symptom control in specific clinical contexts, SLIT offers improved safety and convenience. Treatment choice should therefore be individualized, considering patient characteristics, allergen profile, and risk tolerance.
- 3 February 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 51, 68476
Open AccessSubcutaneous versus Sublingual Allergen Immunotherapy in Allergic Rhinitis and Asthma: A Comparative Narrative Review
Allergen-specific immunotherapy (AIT) represents the only disease-modifying intervention for IgE-mediated allergic diseases, including allergic rhinitis and allergic asthma. Among the currently available administration routes, subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are the most extensively studied and clinically implemented. Despite their widespread use, uncertainty persists regarding their relative efficacy, safety, and real-world applicability across different patient populations and allergen types. AIM: The aim of this study was to critically compare the clinical effectiveness, safety profile, and treatment adherence of SCIT and SLIT based on data derived from PubMed-indexed randomized controlled trials, systematic reviews, and meta-analyses. Material and methods: A narrative synthesis of peer-reviewed literature was conducted, focusing on studies directly or indirectly comparing SCIT and SLIT in patients with allergic rhinitis, allergic asthma, or rhinoconjunctivitis. Primary endpoints included symptom score reduction and medication use, while secondary outcomes encompassed adverse events, immunological responses, and adherence rates. Results: Both SCIT and SLIT demonstrated significant clinical efficacy compared with placebo or pharmacotherapy alone. Overall symptom reduction and medication sparing effects were largely comparable between the two modalities. SCIT showed a trend toward slightly greater efficacy in selected allergens, particularly grass pollen, whereas SLIT consistently exhibited a superior safety profile with fewer systemic adverse reactions. Conclusion: SCIT and SLIT are both effective forms of allergen immunotherapy. While SCIT may provide marginal advantages in symptom control in specific clinical contexts, SLIT offers improved safety and convenience. Treatment choice should therefore be individualized, considering patient characteristics, allergen profile, and risk tolerance.
- Open Access
- 31 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Total hip arthroplasty in elderly patients: treatment-specific considerations, risk of complications, and functional outcomes
Introduction Total hip arthroplasty (THA) is a widely used and effective procedure for treating advanced hip disorders. With population aging, the number of THA procedures in elderly patients is steadily increasing. Advanced age is associated with comorbidities and reduced physiological reserve, which may influence perioperative risk and postoperative outcomes. Aim This review aimed to summarize current evidence on total hip arthroplasty in elderly patients, focusing on surgical management, perioperative care, rehabilitation, and clinical outcomes. Materials and methods A narrative review of the literature was conducted using PubMed, Scopus, and Web of Science databases. Publications between 2001 and 2025 were included. The review focused on adults aged ≥65 years and synthesized findings narratively across surgical indications and management, perioperative care, risk of complications, rehabilitation, and functional outcomes following total hip arthroplasty. Results Available evidence indicates that THA provides significant pain relief and functional improvement in elderly patients, including those aged 80 years and older. Cemented implants are associated with lower early revision rates and better implant survival in patients with poor bone quality, while uncemented and hybrid prostheses may be appropriate in selected cases. Elderly patients have a higher risk of perioperative complications, such as cardiopulmonary events, delirium, and periprosthetic fractures. Early mobilization and structured rehabilitation significantly improve functional recovery and reduce complication rates. Conclusion Total hip arthroplasty is a safe and effective treatment option for elderly patients when individualized surgical planning, comprehensive perioperative management, and multidisciplinary rehabilitation are applied. Advanced age alone should not be considered a contraindication to surgery.
- 31 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Open AccessTotal hip arthroplasty in elderly patients: treatment-specific considerations, risk of complications, and functional outcomes
Introduction Total hip arthroplasty (THA) is a widely used and effective procedure for treating advanced hip disorders. With population aging, the number of THA procedures in elderly patients is steadily increasing. Advanced age is associated with comorbidities and reduced physiological reserve, which may influence perioperative risk and postoperative outcomes. Aim This review aimed to summarize current evidence on total hip arthroplasty in elderly patients, focusing on surgical management, perioperative care, rehabilitation, and clinical outcomes. Materials and methods A narrative review of the literature was conducted using PubMed, Scopus, and Web of Science databases. Publications between 2001 and 2025 were included. The review focused on adults aged ≥65 years and synthesized findings narratively across surgical indications and management, perioperative care, risk of complications, rehabilitation, and functional outcomes following total hip arthroplasty. Results Available evidence indicates that THA provides significant pain relief and functional improvement in elderly patients, including those aged 80 years and older. Cemented implants are associated with lower early revision rates and better implant survival in patients with poor bone quality, while uncemented and hybrid prostheses may be appropriate in selected cases. Elderly patients have a higher risk of perioperative complications, such as cardiopulmonary events, delirium, and periprosthetic fractures. Early mobilization and structured rehabilitation significantly improve functional recovery and reduce complication rates. Conclusion Total hip arthroplasty is a safe and effective treatment option for elderly patients when individualized surgical planning, comprehensive perioperative management, and multidisciplinary rehabilitation are applied. Advanced age alone should not be considered a contraindication to surgery.
- Open Access
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Breast Cancer Risk in Users of Hormonal Contraception
Combined oral contraceptives (COCs) are a widely used method of birth control among women. They have a low Pearl Index, confirming high efficacy. Their mechanism of action relies on suppression of ovulation. This is achieved through the influence of estrogenic and progestogenic components on the release of follicle-stimulating hormone and luteinizing hormone from the pituitary gland. COCs also inhibit fertilization by altering cervical mucus composition and prevent blastocyst implantation. The mechanism of action of COCs allows their use for non-contraceptive purposes. For example, they reduce the risk of ovarian and endometrial cancer. They also limit menstrual bleeding and alleviate acne, migraine headaches, and dysphoric symptoms. Conversely, adverse effects of COCs include an increased risk of cervical cancer. Their impact on breast cancer remains inconclusive. Clinical studies have demonstrated that the overall incidence of breast cancer among women using COCs is comparable to that among women who have never used them. However, during COC use and shortly after discontinuation, the risk of developing breast cancer is elevated, whereas it decreases five years after cessation. Among women with BRCA1 or BRCA2 mutations, the impact of COCs remains uncertain, with some studies reporting increased risk and others suggesting a reduction. Breast cancer is the most frequently diagnosed malignancy among women and the second leading cause of cancer-related death. Prognosis is often dependent on the stage at diagnosis. Mortality risk due to breast cancer is higher among women using COCs, whereas it does not significantly change with the use of progestin-only oral contraceptives. Some patients discontinue oral contraception due to concerns about adverse effects and a potential increase in breast cancer risk. The aim of this study was to present the mechanisms of COC action within breast tissue and their influence on the risk of breast cancer.
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Open AccessBreast Cancer Risk in Users of Hormonal Contraception
Combined oral contraceptives (COCs) are a widely used method of birth control among women. They have a low Pearl Index, confirming high efficacy. Their mechanism of action relies on suppression of ovulation. This is achieved through the influence of estrogenic and progestogenic components on the release of follicle-stimulating hormone and luteinizing hormone from the pituitary gland. COCs also inhibit fertilization by altering cervical mucus composition and prevent blastocyst implantation. The mechanism of action of COCs allows their use for non-contraceptive purposes. For example, they reduce the risk of ovarian and endometrial cancer. They also limit menstrual bleeding and alleviate acne, migraine headaches, and dysphoric symptoms. Conversely, adverse effects of COCs include an increased risk of cervical cancer. Their impact on breast cancer remains inconclusive. Clinical studies have demonstrated that the overall incidence of breast cancer among women using COCs is comparable to that among women who have never used them. However, during COC use and shortly after discontinuation, the risk of developing breast cancer is elevated, whereas it decreases five years after cessation. Among women with BRCA1 or BRCA2 mutations, the impact of COCs remains uncertain, with some studies reporting increased risk and others suggesting a reduction. Breast cancer is the most frequently diagnosed malignancy among women and the second leading cause of cancer-related death. Prognosis is often dependent on the stage at diagnosis. Mortality risk due to breast cancer is higher among women using COCs, whereas it does not significantly change with the use of progestin-only oral contraceptives. Some patients discontinue oral contraception due to concerns about adverse effects and a potential increase in breast cancer risk. The aim of this study was to present the mechanisms of COC action within breast tissue and their influence on the risk of breast cancer.
- Open Access
- 24 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Falls in the Elderly: Determinants, Consequences and Prevention Approaches
Introduction:Falls among older adults are a major global public health problem and a leading cause of injury, disability and mortality in individuals aged 65 years and older. With population aging, the incidence and burden of falls are expected to increase. Falls result from complex interactions between intrinsic age-related changes and extrinsic environmental factors, making them a core geriatric syndrome requiring comprehensive management.Aim:This review aimed to summarize current evidence on the epidemiology, determinants, consequences, and prevention strategies for falls in older adults.Materials and Methods:A narrative review was conducted using PubMed, Scopus, and Web of Science databases. Peer-reviewed articles, meta-analyses, and clinical guidelines published between 2018 and 2025 were included.Results:Approximately one-third of community-dwelling adults aged ≥65 experience at least one fall annually, with higher rates among those aged ≥80 and residents of long-term care facilities. Major risk factors include advanced age, prior falls, gait and balance impairment, muscle weakness, frailty, multimorbidity, polypharmacy, visual and cognitive impairment, and environmental hazards. Falls often lead to fractures, head injuries, functional decline, psychological consequences such as fear of falling, and increased healthcare utilization. Discussion:The findings confirm the multifactorial nature of falls and the cumulative impact of modifiable and non-modifiable risk factors. Psychological consequences, particularly fear of falling, contribute to recurrent falls and progressive functional decline. Conclusions:Falls in older adults represent a complex geriatric syndrome with substantial clinical and socioeconomic consequences. Integrated, multifactorial prevention programs based on comprehensive geriatric assessment are essential to reduce fall risk, maintain independence, and mitigate healthcare system burden.
- 24 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Open AccessFalls in the Elderly: Determinants, Consequences and Prevention Approaches
Introduction:Falls among older adults are a major global public health problem and a leading cause of injury, disability and mortality in individuals aged 65 years and older. With population aging, the incidence and burden of falls are expected to increase. Falls result from complex interactions between intrinsic age-related changes and extrinsic environmental factors, making them a core geriatric syndrome requiring comprehensive management.Aim:This review aimed to summarize current evidence on the epidemiology, determinants, consequences, and prevention strategies for falls in older adults.Materials and Methods:A narrative review was conducted using PubMed, Scopus, and Web of Science databases. Peer-reviewed articles, meta-analyses, and clinical guidelines published between 2018 and 2025 were included.Results:Approximately one-third of community-dwelling adults aged ≥65 experience at least one fall annually, with higher rates among those aged ≥80 and residents of long-term care facilities. Major risk factors include advanced age, prior falls, gait and balance impairment, muscle weakness, frailty, multimorbidity, polypharmacy, visual and cognitive impairment, and environmental hazards. Falls often lead to fractures, head injuries, functional decline, psychological consequences such as fear of falling, and increased healthcare utilization. Discussion:The findings confirm the multifactorial nature of falls and the cumulative impact of modifiable and non-modifiable risk factors. Psychological consequences, particularly fear of falling, contribute to recurrent falls and progressive functional decline. Conclusions:Falls in older adults represent a complex geriatric syndrome with substantial clinical and socioeconomic consequences. Integrated, multifactorial prevention programs based on comprehensive geriatric assessment are essential to reduce fall risk, maintain independence, and mitigate healthcare system burden.
- Open Access
- 10 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67673
GLP-1 Agonists and Dual Agonists in Obesity Treatment: Benefits, Risks, and Clinical Challenges in Geriatric Patients
Introduction. The global prevalence of obesity has increased markedly in recent decades, becoming a major contributor to metabolic syndrome (MetS), cardiovascular disease, and mortality. This trend increasingly affects older adults, in whom obesity often coexists with sarcopenia, frailty, and multimorbidity. Novel pharmacological therapies, particularly glucagon-like peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, have demonstrated unprecedented efficacy in weight reduction, yet data in geriatric populations remain limited. Materials and Methods. A systematic literature search of PubMed, Embase, and Scopus was conducted for studies published between 2020 and 2025. Results. Both semaglutide and tirzepatide produced substantial and sustained weight loss, with mean reductions ranging from approximately 15% to over 20%, and significant improvements in glycemic control, lipid profile, and blood pressure. Tirzepatide consistently achieved greater weight reduction than semaglutide. Limited subgroup and post hoc analyses suggest that older adults experience meaningful metabolic benefits, although higher rates of gastrointestinal adverse events and treatment discontinuation have been reported. Discussion. In older patients, pharmacologically induced weight loss may be accompanied by disproportionate loss of lean body mass, increasing the risk of sarcopenia, frailty, and functional decline. Without appropriate nutritional and exercise interventions, these risks may attenuate the cardiometabolic benefits of treatment. Conclusions. GLP-1 and dual GLP-1/GIP receptor agonists are highly effective therapies for obesity, including in older adults, but require individualized risk–benefit assessment. Integration with nutritional support and resistance training is essential.
- 10 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 49, 67673
Open AccessGLP-1 Agonists and Dual Agonists in Obesity Treatment: Benefits, Risks, and Clinical Challenges in Geriatric Patients
Introduction. The global prevalence of obesity has increased markedly in recent decades, becoming a major contributor to metabolic syndrome (MetS), cardiovascular disease, and mortality. This trend increasingly affects older adults, in whom obesity often coexists with sarcopenia, frailty, and multimorbidity. Novel pharmacological therapies, particularly glucagon-like peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists, have demonstrated unprecedented efficacy in weight reduction, yet data in geriatric populations remain limited. Materials and Methods. A systematic literature search of PubMed, Embase, and Scopus was conducted for studies published between 2020 and 2025. Results. Both semaglutide and tirzepatide produced substantial and sustained weight loss, with mean reductions ranging from approximately 15% to over 20%, and significant improvements in glycemic control, lipid profile, and blood pressure. Tirzepatide consistently achieved greater weight reduction than semaglutide. Limited subgroup and post hoc analyses suggest that older adults experience meaningful metabolic benefits, although higher rates of gastrointestinal adverse events and treatment discontinuation have been reported. Discussion. In older patients, pharmacologically induced weight loss may be accompanied by disproportionate loss of lean body mass, increasing the risk of sarcopenia, frailty, and functional decline. Without appropriate nutritional and exercise interventions, these risks may attenuate the cardiometabolic benefits of treatment. Conclusions. GLP-1 and dual GLP-1/GIP receptor agonists are highly effective therapies for obesity, including in older adults, but require individualized risk–benefit assessment. Integration with nutritional support and resistance training is essential.